Zelnorm (tegaserod) is now approved for chronic idiopathic constipation
April 2006
Zelnorm (tegaserod) is now approved for chronic idiopathic constipation in Canada.
About 2% to 27% of people complain of chronic constipation. Zelnorm is the first prescription drug approved for it.
Zelnorm was initially approved for irritable bowel syndrome in women who primarily have constipation.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive